COMPOSITION COMPRISING AS ACTIVE INGREDIENT L-CARNITINE IN COMBINATION WITH HYDROXYKYNURENNINE-0-BETA-DL-GLUCOSIDE, FOR THE PREVENTION AND/OR TREATMENT OF PATHOLOGIES OF THE EYE DUE TO ULTRAVIOLET RADIATION - Patent 2542233

(19)

(11)

EP 2 542 233 A1

(12)

(43)	Date of publication:
	09.01.2013 Bulletin 2013/02

(21)	Application number: 11702470.3

(22)	Date of filing: 10.02.2011

(51)

International Patent Classification (IPC):

A61K 31/205^(2006.01)
A61P 27/02^(2006.01)

A61K 31/7036^(2006.01)

(86)	International application number:
	PCT/EP2011/051941

(87)	International publication number:
	WO 2011/107334 (09.09.2011 Gazette 2011/36)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

04.03.2010 EP 10155501

(71)	Applicant: SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
	00147 Roma (IT)

(72)	Inventors:
	PESCOSOLIDO, Nicola I-00181 Rome (IT) KOVERECH, Aleardo I-00165 Rome (IT)

(74)	Representative: Tagliafico, Giulia
	Sigma-Tau Industrie Farmaceutiche Riunite SpA Via Pontina Km. 30.400 00040 Pomezia RM 00040 Pomezia RM (IT)

(54)	COMPOSITION COMPRISING AS ACTIVE INGREDIENT L-CARNITINE IN COMBINATION WITH HYDROXYKYNURENNINE-0-BETA-DL-GLUCOSIDE, FOR THE PREVENTION AND/OR TREATMENT OF PATHOLOGIES OF THE EYE DUE TO ULTRAVIOLET RADIATION